Blog

Survey Reveals Site Perspectives on Clinical Trial Services

Posted by Elizabeth Gargill on Tue, Dec 1, 2020

What do doctors and nurses think about solutions designed to make clinical trials easier to conduct? Are they helpful? Do they alleviate burdens? And which ones do they prefer?

In this special Pharma15 Live! segment, BBK Worldwide industry experts Matt Kibby and Aaron Fleishman discuss recent Study Voices survey results that shed light on this topic. They examine doctor and nurse perspectives on services designed to provide support in conducting clinical trials — including services for virtual, hybrid, and decentralized clinical trials.

“We were looking at whether or not doctors and nurses at sites that were conducting clinical trials would appreciate different types of services that assist with their ability to conduct them."

-Matt Kibby, Principal, President, BBK Worldwide

Read More

Topics: Clinical Trials, Pharma15 Live!, Most Viewed, Study Voices, COVID-19, Matt Kibby, Aaron Fleishman, Decentralized Trials, Study Voices 2020, Hybrid Trials

In a new Outsourcing-Pharma interview, Elizabeth Gargill discusses why clinical trial innovation matters more now than ever

Posted by BBK Worldwide on Fri, Oct 23, 2020

 

Earlier this week, Elizabeth Gargill went one-on-one with Outsourcing-Pharma, discussing findings from BBK's recent Study Voices survey that reveal shifts in healthcare consumer attitudes and behaviors since the onset of COVID-19. In this in-depth interview, Elizabeth discusses why clinical trial innovation is more important now than ever before and how clinical trial sponsors can leverage the survey findings to enhance their enrollment and engagement efforts.

Read More

Topics: Patient Engagement, Clinical Trials, Study Voices, Healthcare Consumer, Survey, Clinical Trial Innovations, Clinical Trial Enrollment, Study-life Balance, Outsourcing-Pharma, Telehealth

The Impact of COVID-19 on Clinical Trials: Where Are We? And Where Are We Going?

Posted by Aaron Fleishman, Director, Market Development on Tue, Jun 23, 2020

As the country goes through the phases of reopening, what does that mean for the patient and site experience in clinical trials? PharmaTalkRadio’s Valerie Bowling discusses the future of clinical trials with Ray Dorsey, MD, Matt Kibby, and Craig Lipset in this feature podcast.

Read More

Topics: Clinical Trials, Pharma15 Live!, COVID-19, Matt Kibby, Craig Lipset, Decentralized Trials, Conference Forum

COVID-19 Response Teaches Industry That Investing in Patient Partnership Is Key to All Research Endeavors

Posted by Joan F. Bachenheimer, Founding Principal, CEO on Thu, May 28, 2020

 

Rapid Adoption of Patient-centric Innovation Seen as Positive Outcome of COVID-19 Research Collaborations

While COVID-19 has severely affected many industries, scientific pursuit for a host of medical conditions is also threatened by sharply negative effects of the pandemic on clinical research for non-COVID-19-related pursuits. This is evidenced by an industry-reported 65 percent decline in new patient study enrollment in March 2020 relative to March 2019. The industry is adapting by borrowing from the zealous approach associated with COVID-19 research by deploying extraordinary collaboration and patient-centric services to achieve timelines for as many studies as possible.

Read More

Topics: Patient Centricity, Clinical Research, Clinical Trials, Clinical Trial Innovations, COVID-19, Joan F. Bachenheimer

Bonus Content: COVID-19 and Beyond Virtual Town Hall

Posted by Elizabeth Gargill on Tue, May 26, 2020

More of Your Questions Answered

In this special video clip, industry innovators Aaron Fleishman and Craig Lipset answer some of the overflow questions from our Virtual Town Hall on maintaining clinical trial momentum during COVID-19 and beyond.

This 20-minute segment features answers to your questions relating to:

  • Implementation of decentralized trials
  • Impact of COVID-19 on enrollment of healthy volunteers
  • Biggest concerns for clinicians around remote contact with patients
  • Advancing decentralized trials while not leaving behind people without access to reliable internet, electronic devices, or digital savvy
  • Validating new digital endpoints for decentralized trials
  • Impact of telemedicine and other decentralized trial approaches on  monitoring and source data verification (SDV)

 

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

Watch Now: COVID-19 and Beyond Virtual Town Hall

Posted by Elizabeth Gargill on Tue, May 19, 2020

Driven by audience questions, industry innovators Aaron Fleishman and Craig Lipset discuss maintaining clinical trial momentum during COVID-19 and beyond during our recent virtual town hall.

Watch now to gain insight into overcoming patient enrollment and engagement challenges while supporting study continuity. Learn how to minimize clinical trial disruption with solutions for all stages of study activity – planning, enrolling, and even restarting.

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

"COVID-19 and Beyond" Virtual Town Hall

Posted by Elizabeth Gargill on Wed, May 6, 2020

"COVID-19 and Beyond" Virtual Town Hall - May 14, 2020 @ 12:00 p.m. ET

Join industry innovators Craig Lipset and Aaron Fleishman for a virtual town hall to discuss maintaining clinical trial momentum during COVID-19 and beyond. Register now.

Read More

Topics: Webinars, Clinical Trials, Pharma15 Live!, COVID-19, Aaron Fleishman, Craig Lipset

Now Trending: Social media platforms to keep an eye out for in 2020

Posted by Nicole DeMarco, Media and Research Strategist on Wed, Dec 4, 2019

 

We recently asked BBK’s Media and Research Strategist Nicole DeMarco to look beyond Facebook, Twitter, and Instagram and share her thoughts on what alternative platforms she thinks offer the most promise for life science marketers.

In the life sciences realm of clinical research advertising, the use of social media platforms is essentially more limited than the options available to general marketers, but great opportunities exist to stay creative, relevant, and highly-targeted.

Read More

Topics: BBK Worldwide, Patient Engagement, Social Media, Clinical Trials, Apps, Patient Experience, TikTok

BBK Worldwide Hires Veronica Moore as Account Specialist

Posted by Elizabeth Gargill on Wed, Nov 20, 2019

 

The BBK team is very pleased to welcome Veronica Moore as Account Specialist. An experienced healthcare marketing communications professional, Moore will be responsible for orchestrating all aspects of the development and implementation of client campaigns – from communicating with clients about recruitment strategies and enrollment objectives to the coordination of internal specialists. 

In her role, Moore will provide strategic leadership in the management of projects from kick-off to completion, ensuring clients’ needs are met and expectations exceeded. She will leverage strong operational, communication, and critical thinking skills in overseeing the day-to-day operations of all assigned projects.

Read More

Topics: BBK Worldwide, Clinical Trials, Employees, Account Services

Patient Health Apps - Help or Hype?

Posted by Elizabeth Gargill on Wed, Nov 13, 2019

 

Last month, in partnership with Health Union, we surveyed over 200 patients on health app use. The findings not only dispel some common myths about app use, but they provide valuable insight that members of the clinical research community can leverage to enhance the design, development, and adoption of clinical trial engagement apps.

We recently sat down with Health Union’s COO and Clinical Business Lead, Lauren Lawhon, for a Q&A session to get her take on the survey results.

Read More

Topics: BBK Worldwide, Patient Engagement, Clinical Trials, Study Voices, Health Union, MythBusters, Health Apps